Abstract
MicroRNAs (miRNAs) are pivotal regulators of gene expression and are involved in biological processes spanning from early developmental stages to the intricate process of aging. Extensive research has underscored the fundamental role of miRNAs in orchestrating eukaryotic development, with disruptions in miRNA biogenesis resulting in early lethality. Moreover, perturbations in miRNA function have been implicated in the aging process, particularly in model organisms such as nematodes and flies. miRNAs tend to be clustered in vertebrate genomes, finely modulating an array of biological pathways through clustering within a single transcript. Although extensive research of their developmental roles has been conducted, the potential implications of miRNA clusters in regulating aging remain largely unclear. In this review, we use the Mir-23-27-24 cluster as a paradigm, shedding light on the nuanced physiological functions of miRNA clusters during embryonic development and exploring their potential involvement in the aging process. Moreover, we advocate further research into the intricate interplay among miRNA clusters, particularly the Mir-23-27-24 cluster, in shaping the regulatory landscape of aging.
Similar content being viewed by others
Introduction
MicroRNAs (miRNAs) are short noncoding RNAs known to be involved in gene regulation, and they play unique roles in various organismal systems and processes, spanning early development through aging1,2,3. An extensive body of literature has shown that miRNAs play important roles in the development of eukaryotes, as deletion of essential miRNA biogenesis-related proteins induces early lethality1. In addition, miRNAs play critical roles in regulating diverse biological pathways, and their dysregulation can lead to premature aging, particularly in nematodes and flies4. Optimal miRNA expression is crucial for maintaining homeostasis, and miRNA selectivity enables the spatial and temporal specificities of miRNAs since miRNA expression differs among tissues and developmental stages5. miRNAs that are especially important in critical biological pathways are highly conserved across species, with some occurring as clusters to enable more efficient execution of their functions. miRNA clusters are defined as those that overlap within a primary transcript, are located in adjacent genome loci and are transcribed in the same direction6. Generally, miRNA clusters comprise two to three miRNAs, yet large miRNA clusters also occur, such as the chromosome 19 miRNA cluster (C19MC), which is the largest in the human genome, comprising 46 miRNAs that span ~100 kilobases7. Since individual miRNAs have various target genes, a miRNA cluster ultimately evolves complex regulatory activity, thereby influencing a diverse array of biological processes. Among these miRNA clusters, the Mir-17-92 cluster and Mir-23-27-24 cluster are two of the best characterized and reflect critical functions in embryonic development and disease. As the function of the Mir-17-92 cluster has been extensively reviewed previously8,9, in this review, we use the Mir-23-27-24 cluster as an example to elaborate on why miRNAs tend to cluster together. Although the roles of the Mir-23-27-24 cluster in various diseases, such as cancer, have been relatively well documented10,11,12, its functions in normal physiological processes from embryonic development to tissue homeostasis during aging are less well understood. Specifically, its involvement in regulating aging is underappreciated, with only sparse and inconclusive experimental evidence supporting its role in this context. Thus, we provide a summary of the role of the Mir-23-27-24 cluster in development, followed by a discussion linking these functions to its regulation of the aging process. Hereafter, for clarity in this review, we follow the recommendations of the most updated miRNA annotation consortium, using “Mir-23-27-24” and “MiR23, MiR27, and MiR24” to specifically indicate the mouse gene and mature forms of the miRNAs, respectively, and annotate the respective human forms as “MIR-23-27-24” and “MIR23, MIR27, and MIR24”13. In the following sections, we summarize the roles of the Mir-23-27-24 cluster in development and link its activity to aging regulation.
In most vertebrates, the Mir-23-27-24 cluster comprises two paralogs resulting from a gene duplication event: Cluster a (Mir-23a-27a-24-2) and Cluster b (Mir-23b-27b-24-1) (Fig. 1)14. Mir-23a-27a-24-2 is located intergenically, whereas Mir-23b-27b-24-1 is located intronically within the aminopeptidase O (Aopep) gene. The MiR23, MiR27 and MiR24 miRNA gene families are involved in both gene clusters, with a total of five miRNAs being produced from these miRNA loci (MiR24-1 and MiR24-2 possess an identical mature MiR24 sequence). Although the two paralogous clusters are located on different chromosomes, both harbor three similar miRNAs, with each pair having the exact same seed sequence. Although miRNAs can target the same set of mRNAs based solely on their identical seed sequences, their expression and roles vary across tissues, likely due to versatile transcription and post-transcriptional regulation15. Although these clusters are highly conserved across vertebrates, one cluster is not found in chickens or rabbits. Thus, even though these two paralogous clusters share the same seed sequences, their functions may not be completely identical. The dynamic spatiotemporal expression pattern of the Mir-23-27-24a/b clusters likely increases the complexity of their functions during embryonic development, as many of their target genes might be tightly regulated in the same biological pathways14. This concept is aptly demonstrated by the Mir-17-92 cluster, in which each member may exhibit either cohesive or divergent functions. The Mir-17-92 cluster comprises MiR17, MiR18, MiR19a/b, MiR20, and MiR92. Notably, although the Mir-17-92 cluster functions as a potent oncomir in cancer progression, MiR19a/b has emerged as the primary cluster member responsible for recapitulating the entire cluster phenotype16,17. Conversely, during spinal motor neuron generation, the Mir-17-92 cluster exhibits a cohesive mode of action. In this scenario, MiR19a/b targets phosphatase and tensin homolog (PTEN), whereas MiR17/20 targets the E3 ubiquitin ligases Nedd4 family interacting protein 1 (Ndfip1) and neural precursor cell expressed developmentally downregulated 4-like (Nedd4-2) to regulate PTEN monoubiquitination18,19. Accordingly, knocking out the Mir-17-92 cluster in motor neurons leads to concomitant increases in the expression of PTEN and Ndfip1/Nedd4–2, thereby promoting the translocation of monoubiquitinated PTEN to the nucleus, where it induces motor neuron apoptosis. Thus, individual miRNAs within the Mir-17-92 cluster can coherently regulate the subcellular localization of their target proteins. This scenario might provide an explanation for why miRNAs are generally clustered in mammalian genomes, as clustering allows them to orchestrate target functions by coordinately regulating gene expression and post-translational modifications18,19.
Role of the Mir-23-27-24 clusters in development
Many miRNA clusters have been recognized as critical regulators during development, as germline deletion of some miRNA clusters tends to be embryonically lethal or results in organ defects20. The MIR-17-92 cluster is important for normal development, and it was also the first miRNA cluster to be implicated in human diseases, such as Feingold syndrome21. This cluster is often dysregulated in hematopoietic and solid cancers. Germline deletion of the Mir-17-92 cluster is embryonically lethal, resulting in prominent septal defects and impaired B-cell development20. Moreover, knockout of the Mir-17-92 cluster in a tissue-specific manner also causes notable defects. For example, the deletion of Mir-17-92 in spinal motor neurons induces partial perinatal lethality and gross locomotive deficits18,19.
Stem cell differentiation
Another pivotal miRNA cluster for mammalian embryonic development is Mir-23-27-24 (Fig. 2). At the early stage of development, the paralogous MIR-23-27-24 clusters are highly expressed during stem cell differentiation. For example, during hepatocyte differentiation, both MIR23b and MIR27b are upregulated during the transition of human embryonic stem cells (hESCs) into hESC-derived definitive endoderm cells22. Similarly, MIR24 is upregulated during the transition of hESC-derived definitive endoderm cells into hepatocytes22. Furthermore, MIR23a, MIR23b, MIR27a and MIR27b were found to be enriched in the definitive endoderm stage, as was MIR23 in the hepatocyte stage22, demonstrating the importance of these miRNAs in closely regulating the different stages of stem cell differentiation. MiR27a and MiR24 also act as suppressors of ESC self-renewal, and inhibiting the expression of these molecules promotes somatic cell reprogramming23. Knockout analysis involving loss of both MiR27 and MiR24 revealed somatic cell reprogramming and severe defects in mesoderm differentiation of ESCs23. Notably, the same study revealed that MIR23a-3p is one of the few miRNAs enriched in mouse embryonic fibroblasts, and this molecule is also upregulated during embryoid body differentiation. This study further established the role of the Mir-23-27-24 cluster in early development and demonstrated that its members exert their own specific functions.
In contrast to MiR27a and MiR24, MiR23a represses endoderm and ectoderm differentiation by suppressing two differentiation markers, SRY-box transcription factor 17 (Sox17) and alpha fetoprotein (Afp)24. A notable increase in the activation of mouse endodermal genes, including Afp, Sox17, and GATA binding protein 6 and 4, and ectodermal genes, such as ISL LIM homeobox 1 (Islet1), fibroblast growth factor 5 (Fgf5), and SRY-box transcription factor 1 (Sox1), was observed following MiR23a inhibition, although markers for trophectoderm and mesoderm lineages remained unaffected. Notably, MiR23a overexpression in mouse ESCs suppressed differentiation toward these lineages, suggesting that MiR23a plays a crucial role in maintaining pluripotency. These findings unequivocally establish MiR23a as an additional regulator of ESC differentiation. In addition to the endoderm lineage, mesendoderm formation is also a crucial step in embryogenesis and is controlled by bone morphogenetic signaling. In this case, MIR27b has been found to play an important role by repressing mediators of bone morphogenetic protein signaling, e.g., phosphorylated SMAD1/5, throughout the definitive endoderm differentiation of human induced pluripotent stem cells by promoting mesoderm formation25.
Noise buffering in neuronal progenitors
The Mir-23-27-24 cluster is also involved in orchestrating tissue morphogenesis during embryonic development. For example, the Mir-23-27-24 cluster plays multifaceted roles during neural development. Upon neural tube closure, the initial rostrocaudal patterning of the neural tube leads to differential expression of Hox genes that contribute to the specification of motor neuron subtype identity26. Although several Hox mRNAs are expressed in motor neuron progenitors in a fluctuating manner, the Hox proteins are not expressed in these progenitors and become detectable only in postmitotic motor neurons27. Interestingly, the homeobox A5 (Hoxa5) protein is precociously expressed in progenitors, and the Hox5/8 boundary is expanded caudally in conditional mutants for Dicer (encoding a principle enzyme for miRNA biogenesis), both in vitro and in vivo. In silico simulations revealed that two feed-forward Hox-miRNA loops account for precocious and fluctuating Hoxa5 expression, as well as the ill-defined boundary phenotype of Dicer mutants27,28. Within the Mir-23-27-24 cluster, MiR27 appears to be a major regulator coordinating the temporal delay and spatial boundary of Hox protein expression27. These results describe a novel Hox-miRNA circuit that filters transcription noise and controls the timing of protein expression to confer robust individual motor neuron identity. More interestingly, the same set of miRNAs participates in two feed-forward loops, with the potential to buffer transcriptional noise and sharpen the boundary. This novel miRNA-mediated mechanism represents a powerful strategy for endowing precision and robustness to morphogen-mediated pattern formation27.
Establishment of neuronal identity via bistability
In addition to its impacts on neural progenitors, MiR27 also participates in tuning the establishment of neuronal identity29. The lineage commitment of spinal motor neurons in the cervical region is marked by a clear segregation of two lineage-determining transcription factors, e.g., Hoxa5 and Hoxc830. However, using single-cell RNA sequencing and mouse genetic lineage tracing, our group revealed that the fate decisions of the cells at the boundary are achieved without segregating the mRNAs of the two Hox genes29. Furthermore, transcriptional cross-repression between these two factors, i.e., through a classical feedback loop, does not occur. These observations challenge existing paradigms of the feedback mechanisms underlying cell fate decisions. This novel type of feedback mechanism has not been reported previously, and it is estimated that there are at least 104 distinct mRNA‒miRNA reaction systems that match this bistability-enabling topology in human cells29. This new theory of miRNA‒mRNA circuits can be applied to a wide range of systems31 in addition to the already known rich dynamics of post-transcriptional reaction networks widespread in biology, along with a novel mechanism involved in regenerating multimodal gene expression in cell populations32.
Roles of the Mir-23-27-24 cluster in aging
Aging is one of the most pressing socioeconomic and health problems of the twenty-first century. It represents the predominant risk factor for most human pathologies, including cardiovascular diseases, neurological disorders, and cancer. Medical interventions to impede the aging process would substantially impact human disease. Currently, aging is characterized by the progressive dysfunction of multiple organs and tissues within an organism. For almost all late-onset neurodegenerative disorders—such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis—aging is the only known common risk factor33. Deciphering the molecular mechanisms underlying aging could not only reduce the prodigious costs of medical care for patients suffering from aging-induced pathologies and disorders but also provide a key step toward the long-held aspiration of human beings, e.g., the fountain of youth and healthy longevity. Not surprisingly, miRNAs have been identified as functional regulators of the aging process via a specific “regulome”. Not only do miRNAs manifest spatiotemporal expression patterns during embryonic development, but many studies have revealed distinctive patterns of miRNA expression in different organs upon aging34,35. However, more thorough research on this topic is warranted. Generally, aging can be characterized by several interconnected molecular hallmarks, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis (Fig. 3)36,37. Intriguingly, the Mir-23-27-24 clusters participate in a series of molecular pathways contributing to these aging hallmarks, suggesting that they play underappreciated roles in the aging process. Notably, previous studies have reported conflicting results regarding the effects of overexpressing or deleting members of the Mir-23-27-24 cluster on aging. These discrepancies can be attributed to the dual targeting modes of miRNAs, e.g., binary switches or tuning interactions38. In tuning interactions, optimal miRNA expression levels function as a rheostat, finely regulating target expression within physiological ranges. Deviations from this balance can lead to either excessive or insufficient target expression, impairing the ability of a cell or organism to respond effectively to stress. Moreover, MiR27 may undergo target-directed miRNA degradation (TDMD), complicating predictions about its overexpression effects29,39. Given that aging involves a complex interplay of various factors across different cell types and tissues, it is crucial to determine the physiological expression levels of each Mir-23-27-24 cluster member and its targets in a cell-type-specific manner during aging. This knowledge will inform decisions about appropriate stoichiometry and expression levels when considering interventions to augment Mir-23-27-24 cluster members to manipulate the aging process. Below, we explore the roles of the Mir-23-27-24 clusters in regulating various hallmarks of aging37, exemplifying how such miRNAs might contribute to aging regulation, whether miRNA clusters are more likely to be involved in manipulating the pace of aging (Fig. 3) and summarized the involved aging hallmarks in Table 1.
Genomic instability
Genome stability is crucial to the growth, development, functioning, and reproduction of all living organisms. In general, genomic instability arises from alterations in the structure or number of chromosomes, point mutations within genes, and other forms of genetic changes40,41. Although such instability can be a natural element of cellular processes, uncontrolled genomic instability results in diseases such as cancer and aging42,43. Dysregulation of miRNAs has been found to be a clear modulator of genomic instability, with emerging research centering on cancer and the DNA damage response44,45,46.
The MIR-23-27-24 clusters potentially play a role in human aging by regulating several important DNA damage response genes37,38, such as H2A.X variant histone (H2AX) and BCL2 like 11 (BCL2L11), as well as melatonin-activated pathway genes, such as mitogen-activated protein kinase 14 (MAPK14), tumor protein p53 (TP53), and PML nuclear body scaffold (PML)47. This role is exemplified in post-thymic CD8+ T cell differentiation when the MIR-23-27-24 cluster is upregulated48. In that study, increased MIR24 expression reduced the expression of the histone variant H2AX, which is crucial for DNA damage response pathways. Melatonin can reduce DNA fragmentation only when MIR24 is expressed at physiological levels, indicating that the ability of melatonin to protect cells from DNA damage requires the downregulation of MIR24 expression47. Another study reported the ability of MiR24 to inhibit BRCA1 in the homologous recombination DNA repair pathway49, with BRCA1 expression inversely correlated with MiR24 levels in lung tissue specimens from a chronic obstructive pulmonary disease model.
Telomere attrition
Telomeres are specialized regions of repetitive DNA sequences at the termini of chromosomes that become shorter with each cell division, indicating that telomere length is a good marker in the context of aging and age-related diseases such as AD and chronic obstructive pulmonary disease50. Shelterin, or telosome, a protein complex associated with telomeres, ensures telomere integrity, safeguards telomeres from being recognized as DNA breaks, and synchronizes telomerase-dependent maintenance of telomere length51. Many miRNAs have been linked to regulating proteins in the shelterin complex. For instance, elevated MIR185 promotes telomere elongation and simultaneously accelerates the replicative senescence process in a protection of telomeres 1 (POT1)-dependent manner52. miRNAs also contribute to mechanisms to maintain telomere length, such as telomerase activity and alternative lengthening of telomeres (ALT). For example, MIR708 was shown to be highly expressed in a large panel of cells that underwent ALT, and its overexpression suppressed cell migration, invasion, and angiogenesis53.
Through its targeting of telomeric repeat binding factor 2 (TRF2), a double-stranded DNA binding protein important for protecting telomere ends and T-loop formation, MIR23a of the MIR-23-27-24 clusters has been associated with telomere dysfunction. Overexpressing MIR23a in human primary fibroblasts ultimately limited TRF2 targeting to telomere chromatin, leading to telomere dysfunction-induced foci and ataxia-telangiectasia-associated signaling activation54. Notably, the same group reported increased senescence in MIR23a-overexpressing cells, and this effect was reversed upon coexpression of exogenous TRF2, indicating that MIR23a regulates telomere maintenance and senescence by directly inhibiting TRF255.
Epigenetic dysregulation
Various epigenetic alterations contribute to the aging process, including alterations in the acetylation and methylation of DNA or histones and in the levels or activity of chromatin-associated proteins or noncoding RNAs (ncRNAs)56. Numerous reviews have summarized and demonstrated a strong link between miRNAs and epigenetic regulation, with other ncRNAs also participating in the epigenetic landscape57,58. miRNAs can function as epigenetic modulators by acting on enzymes important in epigenetic reactions, such as DNA methyltransferases and histone methyltransferases. Concurrently, the epigenetic landscape regulates miRNAs by governing DNA methylation, RNA modification and histone modification on these small ncRNAs59,60,61. For example, DNA methylation of the promoter region of MIR410 is more prominent in glioma tissues, resulting in reduced MIR410 expression in gliomas, and gain- and loss-of-function experiments further support that MIR410 significantly controls cell growth, cell cycle progression, and glioma cell apoptosis62. Such epigenetic mechanisms regulate gene expression without affecting genome sequences.
The MIR-23-27-24 cluster has been shown to target hypermethylated in cancer 1 (HIC1). Interestingly, HIC1 represses transcription to control the expression of the MIR-23-27-24 clusters by binding to HIC1-binding motifs, forming a double-negative feedback loop that ultimately contributes to breast cancer progression10. MIR24-2 has also been reported to be involved in many aspects of epigenetic regulation by targeting protein arginine methyltransferase 7 (PRMT7), thereby inhibiting dimethylation/trimethylation of histone H4 arginine 3 and eventually promoting the expression of Nanog via hepatocellular carcinoma-upregulated long noncoding RNA (HULC)63. Another study revealed the importance of MIR24-2 in epigenetic regulation since it increases the expression of both the N6-adenosine-methyltransferases METTL3 and MIR6079 via RNA methylation. Lysine demethylase 4A (JMJD2A), a target of MIR6079, promotes the trimethylation of histone H3 on the ninth lysine (H3K9me3)64. Moreover, MIR24-2 impacts several epigenetics-related genes, including pHistone H3, SUZ12 polycomb repressive complex 2 subunit (SUZ12), histone lysine methyltransferase SUV39H1, Nanog, mitogen-activated protein kinase kinase kinase 4 (MEKK4) and phosphotyrosine (pTyr)64. Together, these findings demonstrate that MIR24-2 of the MIR-23-27-24 cluster is an important epigenetic regulator and thus might be crucial in the aging process.
Disabled macroautophagy
Autophagy is a cellular process crucial to cell survival that involves the degradation and recycling of cellular components, such as damaged organelles and proteins, to maintain cellular health and homeostasis. This intracellular catabolic process encompasses microautophagy, macroautophagy and chaperone-mediated autophagy. In macroautophagy, engulfed substrates are sequestered within cytosolic double-membrane vesicles, termed autophagosomes65. Macroautophagy targets nonproteinaceous macromolecules and entire organelles, and when this process is impaired, such as during aging, organelle turnover and responsiveness to environmental stresses can be negatively impacted. Notably, extracellular vesicle-encapsulated mir-83 in Caenorhabditis elegans represses the expression of an autophagy regulator, Mucolipin 1 (CUP-5/MCOLN), with mir-83 expression levels increasing with age in the intestine, highlighting a role for this miRNA in coordinating macroautophagic events during the aging process66.
Similarly, MiR23a has been strongly linked to autophagy because it targets apoptosis signal-regulating kinase 1 (ASK-1), limiting the apoptosis of cumulus cells in yaks (Bos grunniens)67. Moreover, both MIR27a and MIR27b regulate mitochondrial autophagy by repressing the mRNA of PTEN-induced putative kinase 1 (PINK1)68, thereby preventing the PINK1 accumulation that occurs upon mitochondrial damage and curtailing mitophagic influx. Interestingly, under chronic mitophagic flux, the expression of both of these miRNAs was significantly upregulated, indicating a negative feedback mechanism between PINK1-mediated mitophagy and the MIR-23-27-24 cluster.
Deregulated nutrient-sensing
Diet has a powerful modulatory influence on aging, and caloric restriction has emerged as a valuable intervention in this regard69. However, many questions about how caloric intake controls aging-related processes remain unanswered. Nutrient-sensing pathways become dysregulated and lose effectiveness with age. Fully understanding the underlying mechanisms is a critical step for discovering therapeutic strategies. Diet has also been shown to have an important influence on miRNAs. Notably, certain miRNAs affect proteins and enzymes involved in nutrient-sensing pathways and thus may contribute to modulating the aging process. For instance, reduced levels of the miRNA lin-4 in C. elegans decreased the lifespan and accelerated tissue aging, whereas overexpressing lin-4 extended life through the insulin/insulin-like growth factor-1 pathway70. Moreover, the p53 homolog in Drosophila (Dp53) is synchronized by miR-305 in a nutrient-dependent manner. In well-fed flies, Target of Rapamycin (TOR) signaling results in miR-305-mediated inhibition of Dp53, whereas nutrient deprivation reduces the levels of miR-305 and promotes Dp53 derepression, indicating a role for Dp53 targeting by miR-305 in nutrient-sensing and metabolic adaptation71.
The involvement of the Mir-23-27-24 cluster in sensing and regulating extrinsic signals related to aging is also noteworthy. Both MiR23 and MiR27 have been implicated in deregulated nutrient-sensing through their suppression of Sprouty2 (SPRY2) and Semaphorin 6A (Sema6A), respectively, which negatively regulate Ras/mitogen-activated protein kinase (Ras/MAPK) and vascular endothelial growth factor receptor 2 (Vegfr2)-mediated signaling, thereby promoting angiogenesis72. Moreover, both the MAP and phosphatidylinositol 3’-kinase (PI3K)-Akt kinase signaling pathways (which are also important in nutrient-sensing) are activated when vascular endothelial growth factor (Vegf) binds to its receptors. In contrast, loss of MiR23/27 impaired MAPK and Vegfr2 signaling in response to Vegf, resulting in angiogenic suppression. Loss of the Mir-23-27-24 cluster in the myeloid lineage of mice elicits an interesting phenotype, in which these mice gain less weight on a high-fat diet than controls while simultaneously exhibiting exacerbated glucose and insulin tolerance owing to a reduced population of lipid-associated macrophages73. The authors of that study attributed this outcome to MiR23 targeting eukaryotic translation initiation factor 4E binding protein 2 (Eif4ebp2), an essential gene that restricts protein synthesis and proliferation in macrophages. Thus, the Mir-23-27-24 clusters can impact different hallmarks of aging, including deregulated nutrient-sensing, loss of proteostasis, and chronic inflammation.
Mitochondrial dysfunction
As cell powerhouses, mitochondria contribute significantly to the aging phenotype. Mitochondrial function starts to deteriorate upon aging owing to multiple intertwined mechanisms involving other aging hallmarks, including the accumulation of mitochondrial DNA mutations, destabilization of respiratory chain complexes, reduced mitochondrial turnover, and changes in mitochondrial dynamics. These events tend to increase the production of reactive oxygen species (ROS), which alter mitochondrial membrane permeability and promote inflammation and autophagy74. A group of miRNAs located in or associated with mitochondrial functions, collectively termed mitomiRs, trigger macrophage differentiation and modulate their downstream activation and immune functions75. Moreover, mitomiRs contribute to cardiac diseases and have proven important in elucidating how miRNAs regulate mitochondrial RNAs in cells lacking mitochondrial DNA76,77. For example, during muscle differentiation, the myogenesis-specific miRNA MIR1 enters mitochondria to activate the translation of various mitochondrial genome-encoded transcripts78.
In the MIR-23-27-24 cluster, MIR27 targets the 3′ untranslated region (UTR) of the mRNA of mitochondrial fission factor (MFF) to limit its expression. In doing so, MIR27 regulates mitochondrial dynamics by controlling mitochondrial elongation, membrane potential, and ATP levels79. Furthermore, both MIR23a and MIR23b are downregulated by c-Myc, an oncogenic transcription factor, resulting in impaired mitochondrial glutaminase (GLS) activity and reactive oxygen species homeostasis, thereby increasing glutamine catabolism to promote ATP production and glutathione synthesis80.
Cellular senescence
Cells undergo cellular senescence primarily due to chronic stress or cellular damage, a process that is triggered at least in part by telomere shortening with aging. Given the considerable stress on aging cells, many cells enter a cellular senescence state to suppress replication, ultimately perturbing organismal homeostasis. A set of miRNAs—including MIR210, MIR376a*, MIR486-5p, MIR494, and MIR542-5p—induce double-strand DNA breaks and ROS accumulation as a consequence of cell senescence81. The miRNA let-7 interacts with argonaute RISC catalytic component 2 (AGO2), which accumulates in senescent cells and silences gene transcription82. Thus, miRNAs are involved in senescence either by inducing senescence through double-strand DNA break accumulation or gene silencing.
The paralogous MIR-23-27-24 clusters also regulate this aging hallmark, with MIR24 overexpression inducing the downregulation of DNA topoisomerase I (TOP1), an enzyme responsible for controlling and altering the topological state of DNA during transcription, which is especially important for maintaining genome stability and organization83. MIR24-induced downregulation of TOP1 causes DNA damage and stabilizes p53, providing favorable conditions for fibroblasts to undergo stress-induced premature senescence84. Moreover, MIR23a has been linked to senescence-associated skin aging by targeting the polysaccharide hyaluronan synthase 2 (HAS2) in the extracellular matrix85. Overexpression of MiR23a in nonsenescent mouse fibroblasts reduces Has2 levels and increases those of senescence-associated markers in mice, mimicking the normal aging process in vivo.
Stem cell exhaustion
Stem cell differentiation is critically important since it enables differentiated cell types to perform their specific functions, especially during development. During aging, this process facilitates tissue repair upon injury or pathogenic infection. Certain miRNAs are important regulators of stem cells, and the loss of the primary enzymes responsible for miRNA biogenesis, such as Dicer or the microprocessor complex subunit DGCR8, impairs ESC differentiation86. For example, MiR145, MiR296, MiR470 and MiR134 target transcription factors such as POU class 5 homeobox 1 (Oct4) and SRY-box transcription factor 2 (Sox2) to regulate stem cell differentiation87,88. Notably, both ESCs and oocytes lack an antiviral mechanism because they are intrinsically incapable of producing interferons, a feature attributable to MiR673-driven control of mitochondrial antiviral signaling protein (MAVS), which regulates interferon production89.
In ESCs, the Mir-23-27-24 cluster is regulated by bone morphogenetic protein 4 (Bmp4), which recruits phosphorylated SMADs to the promoter of the gene encoding the miRNA clusters. Instead of affecting self-renewal or pluripotency, this regulatory mechanism promotes ESC differentiation, inducing apoptosis in epiblast stem cells upon their differentiation. MiR23 also targets SMAD family member 5 (Smad5), a transcription factor downstream of the Bmp4 receptor, increasing the complexity of this Mir-23-27-24/apoptosis regulatory loop90. Furthermore, both MiR23a and MiR23b play a role in the differentiation of bone marrow mesenchymal stem cells into osteoblasts by targeting transmembrane protein 64 (Tmem64)91. Notably, excess expression of MiR23a and MiR23b promotes osteogenic differentiation, whereas inhibiting these miRNAs induces adipogenic differentiation, revealing a potential therapeutic approach for age-related osteoporosis. Although the role of the Mir-23-27-24 clusters in the stem cell differentiation process is clear, their function in the stem cell exhaustion process during aging is less clear. One example is the targeting of the 3′ UTR of paired box 3 (Pax3) mRNA by MiR27b, which is required for the maintenance of skeletal muscle stem cells and their migration, both in the embryonic and adult stages92. By altering the expression of MiR27b, stem cell proliferation and the onset of differentiation are greatly affected, indicating that the regulation of Pax3 by MiR27b is crucial for the myogenic differentiation program in skeletal muscle.
Altered intercellular communication
Communication between cells is essential for normal homeostatic functions, and cells displaying compromised communication ultimately exhibit deterioration of tissue health. The reduction in or loss of communication that arises during aging results in increased system noise encompassing both homeostatic and hormetic regulation, which is relevant to whether aging occurs systemically or begins from a certain tissue. miRNAs play an important role in intercellular communication, as they can be transported in extracellular vesicles within various body fluids—including plasma, serum, cerebrospinal fluid and urine—to regulate mRNA expression in remote target cells, including tumor and diseased cells93. miRNAs can also travel through gap junctions between cells in a connexin-dependent manner, thereby enabling coordinated cell proliferation and differentiation94. This scenario reveals another interesting facet of how miRNAs regulate the aging process, as they can be trafficked during multicellular development to specific organs, where they can synchronize both cell proliferation and differentiation.
The roles of the Mir-23-27-24 cluster in altering intercellular communication have also been explored. Inhibiting both MiR23a and MiR23b in lymphoma cells increased the rate of cell death and apoptosis due to their binding to the cell surface death receptor (Fas) mRNA, which encodes a cellular signaling protein95. Intriguingly, that study revealed that MiR23a was much more effective at repressing Fas than was MiR23b, with the stronger regulatory effect of MiR23a attributable to an additional sequence beyond the conserved seed sequence, providing further evidence that despite having the same seed sequences, miRNAs can still exert tissue specificity. MiR27b has also been found to affect various signaling pathways by targeting SMAD family member 4 (Smad4), resulting in increased levels of Wnt family member 1 (Wnt1), β-catenin, c-Myc, and cyclin D196. In contrast, inhibiting MIR27a expression upregulated secreted frizzled-related protein 1 (SFRP1), suppressed Wnt/β-catenin signaling, and significantly reduced cyclin D1 expression levels97.
Chronic inflammation
One of the most important hallmarks of aging is chronic inflammation, reflected by elevated levels of proinflammatory markers in cells and tissues arising from dysregulation of immune cells, defective immunosurveillance or loss of self-tolerance. Many miRNAs are involved in these effects, either in their encapsulated form within extracellular vesicles for transport between different macrophages98 or by mediating inflammation-induced suppression of neural stem cell self-renewal, as is the case for MIR15599.
In the context of MIR-23-27-24, MIR23b is downregulated by interleukin 7A (IL-17), which contributes to rheumatoid arthritis. MIR23b can mitigate this effect by suppressing the expression of TGF-β-activated kinase 1/MAP3K7 binding protein 2 (TAB2), TAB3 and inhibitor of nuclear factor κ-B kinase subunit α (IKK-α), reflecting its potential as a target for inflammatory autoimmune therapeutic strategies100. MIR23a, which shares an identical seed sequence with MIR23b, also regulates inflammation by targeting IKKα in primary articular chondrocytes to inhibit IL-17-induced proinflammatory mediators101. Another research group revealed how the miRNAs of this cluster in macrophages activate the NF-ĸB proinflammatory pathway while inhibiting anti-inflammatory pathways102. In this case, MiR23a activates the NF-κB pathway by targeting TNF alpha-induced protein 3 (A20), thereby promoting proinflammatory cytokine production. MiR23a and MiR27a suppress Jak1/Stat6 and Irf4/Ppar-γ of the Jak1/Stat6 pathway, respectively, again supporting how the Mir-23-27-24 clusters adopt a double-negative feedback loop in macrophage polarization networks, further providing evidence of their key regulatory activity in cancer progression. Another member of the cluster, MiR24, targets chitinase 3-like 1 (Chi3l1) to regulate cytokine synthesis and macrophage survival, and it also promotes aortic smooth muscle cell migration and cytokine production, leading to abdominal aortic aneurysms103, highlighting a novel plasma biomarker for monitoring the progression of this specific type of aneurysm. Together, these findings illustrate the role of these paralogous miRNA clusters in different biological contexts through divergent concentrations in different tissues despite having the same seed sequence.
Future perspectives
In this review, we present Mir-23-27-24 as an exemplary model to succinctly outline the implications of miRNA clusters in both developmental processes and aging. Although the importance of the Mir-23-27-24 cluster in embryonic development is well established, its precise physiological roles in tissue maturation and aging remain unclear, primarily due to the prevailing focus of current research on specific pathways, resulting in a lack of studies of the broader systemic roles of such clusters. Future investigations could elucidate the nuanced involvement of Mir-23-27-24 in aging. First, although the Mir-23-27-24 cluster contributes to numerous molecular hallmarks of aging, existing studies often rely on in vitro cell culture models, providing only superficial insights. Moreover, most miRNA studies pertaining to age-related changes lack robust causal evidence, necessitating parallel in vivo studies utilizing gain- or loss-of-function animal models to establish causal links between associated molecular signatures and the aging process. While efforts in model organisms such as flies and nematodes have been showcased4, comprehensive evaluations in mouse models are needed. Notably, our group demonstrated lethality and neural tube patterning abnormalities in Mir-23-27-24 double knockout mice27,29, demonstrating the critical roles of these miRNAs in embryos. Given that Mir-23-27-24 floxed mice have also been generated104,105,106,107, they represent an ideal platform for further exploration of the tissue-specific functions of the Mir-23-27-24 clusters in adult mice and their relevance to tissue aging. Furthermore, given the distinct roles of individual miRNAs within the Mir-23-27-24 cluster, dissecting their collective and individual contributions to aging through the generation of individual miRNA knockout mice represents an intriguing avenue for cooperative investigation. Second, an important question arises regarding the aging “regulome” governed by the Mir-23-27-24 cluster, i.e., is there a tissue-specific miRNA-mediated aging regulome or is there a common aging regulome across different tissues? Advances in single-cell multiomics techniques hold promise for resolving this issue in the near future. Finally, the potential of miRNA-based therapies in ameliorating neurodegenerative diseases or intervening in the aging process warrants consideration, especially in light of the prominence of RNA vaccines post-COVID-19. This topic is at the forefront of pharmaceutical focus in the coming years.
References
Bartel, D. P. Metazoan microRNAs. Cell 173, 20–51 (2018).
Chang, S. H., Su, Y. C., Chang, M. & Chen, J. A. MicroRNAs mediate precise control of spinal interneuron populations to exert delicate sensory-to-motor outputs. Elife 10, e63768 (2021).
Chen, J. A. et al. Mir-17-3p controls spinal neural progenitor patterning by regulating Olig2/Irx3 cross-repressive loop. Neuron 69, 721–735 (2011).
Kinser, H. E. & Pincus, Z. MicroRNAs as modulators of longevity and the aging process. Hum. Genet. 139, 291–308 (2020).
Farh, K. K. et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310, 1817–1821 (2005).
Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L. & Bradley, A. Identification of Mammalian microRNA host genes and transcription units. Genome Res. 14, 1902–1910 (2004).
Ware, A. P., Satyamoorthy, K. & Paul, B. Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer. Funct. Integr. Genomics 23, 266 (2023).
Mendell, J. T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133, 217–222 (2008).
Olive, V., Li, Q. & He, L. mir-17-92: a polycistronic oncomir with pleiotropic functions. Immunol. Rev. 253, 158–166 (2013).
Wang, Y. et al. HIC1 and miR-23~27~24 clusters form a double-negative feedback loop in breast cancer. Cell Death Differ. 24, 421–432 (2017).
Zhang, H. et al. Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat. Commun. 2, 554 (2011).
Hua, K. et al. MicroRNA‑23a/27a/24‑2 cluster promotes gastric cancer cell proliferation synergistically. Oncol. Lett. 16, 2319–2325 (2018).
Desvignes, T. et al. miRNA nomenclature: a view incorporating genetic origins, biosynthetic pathways, and sequence variants. Trends Genet. 31, 613–626 (2015).
Liang, T., Yu, J., Liu, C. & Guo, L. An exploration of evolution, maturation, expression and function relationships in mir-23 approximately 27 approximately 24 cluster. PLoS ONE 9, e106223 (2014).
Michlewski, G. & Cáceres, J. F. Post-transcriptional control of miRNA biogenesis. RNA 25, 1–16 (2019).
Olive, V. et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23, 2839–2849 (2009).
Mu, P. et al. Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23, 2806–2811 (2009).
Tung, Y.-T. et al. Mir-17∼92 governs motor neuron subtype survival by mediating nuclear PTEN. Cell Rep. 11, 1305–1318 (2015).
Tung, Y.-T. et al. Mir-17∼92 confers motor neuron subtype differential resistance to ALS-associated degeneration. Cell Stem Cell 25, 193.e7–209.e7 (2019).
Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the mir-17∼92 family of miRNA clusters. Cell 132, 875–886 (2008).
de Pontual, L. et al. Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat. Genet. 43, 1026–1030 (2011).
Kim, N. et al. Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation. Hepatol. Res. 41, 170–183 (2011).
Ma, Y. et al. Functional screen reveals essential roles of miR-27a/24 in differentiation of embryonic stem cells. EMBO J. 34, 361–378 (2015).
Hadjimichael, C., Nikolaou, C., Papamatheakis, J. & Kretsovali, A. MicroRNAs for fine-tuning of mouse embryonic stem cell fate decision through regulation of TGF-β signaling. Stem Cell Rep. 6, 292–301 (2016).
Lim, J., Sakai, E., Sakurai, F. & Mizuguchi, H. miR-27b antagonizes BMP signaling in early differentiation of human induced pluripotent stem cells. Sci. Rep. 11, 19820 (2021).
Miller, A. & Dasen, J. S. Establishing and maintaining Hox profiles during spinal cord development. Semin. Cell Dev. Biol. 152-153, 44–57 (2024).
Li, C.-J. et al. MicroRNA filters Hox temporal transcription noise to confer boundary formation in the spinal cord. Nat. Commun. 8, 14685 (2017).
Chen, T.-H. & Chen, J.-A. Multifaceted roles of microRNAs: From motor neuron generation in embryos to degeneration in spinal muscular atrophy. eLife 8, e50848 (2019).
Li, C.-J. et al. MicroRNA governs bistable cell differentiation and lineage segregation via a noncanonical feedback. Mol. Syst. Biol. 17, e9945 (2021).
Dasen, J. S., Tice, B. C., Brenner-Morton, S. & Jessell, T. M. A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell 123, 477–491 (2005).
Nordick, B., Chae-Yeon Park, M., Quaranta, V. & Hong, T. Cooperative RNA degradation stabilizes intermediate epithelial-mesenchymal states and supports a phenotypic continuum. iScience 25, 105224 (2022).
Nordick, B., Yu, P. Y., Liao, G. & Hong, T. Nonmodular oscillator and switch based on RNA decay drive regeneration of multimodal gene expression. Nucleic Acids Res. 50, 3693–3708 (2022).
Gan, L., Cookson, M. R., Petrucelli, L. & La Spada, A. R. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat. Neurosci. 21, 1300–1309 (2018).
Wagner, V. et al. Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissues. Nat. Biotechnol. 42, 109–118 (2023).
Salignon, J. et al. Age prediction from human blood plasma using proteomic and small RNA data: a comparative analysis. Aging 15, 5240–5265 (2023).
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).
Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009).
Sheu-Gruttadauria, J. et al. Structural basis for target-directed microRNA degradation. Mol. Cell 75, 1243.e7–1255.e7 (2019).
McKinney, J. A. et al. Distinct DNA repair pathways cause genomic instability at alternative DNA structures. Nat. Commun. 11, 236 (2020).
Passerini, V. et al. The presence of extra chromosomes leads to genomic instability. Nat. Commun. 7, 10754 (2016).
Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467–472 (2018).
Oberdoerffer, P. & Sinclair, D. A. The role of nuclear architecture in genomic instability and ageing. Nat. Rev. Mol. Cell Biol. 8, 692–702 (2007).
Wang, T. et al. miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer. Cell Death Dis. 10, 495 (2019).
Kato, M. et al. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28, 2419–2424 (2009).
Zhang, X., Wan, G., Berger, F. G., He, X. & Lu, X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 41, 371–383 (2011).
Mori, F. et al. Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects. Oncotarget 7, 20532–20548 (2016).
Brunner, S. et al. Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8+ T cells sensitizing them to apoptotic cell death. Aging Cell 11, 579–587 (2012).
Nouws, J. et al. MicroRNA miR-24-3p reduces DNA damage responses, apoptosis, and susceptibility to chronic obstructive pulmonary disease. JCI Insight 6, e134218 (2021).
Rossiello, F., Jurk, D., Passos, J. F. & d’Adda di Fagagna, F. Telomere dysfunction in ageing and age-related diseases. Nat. Cell Biol. 24, 135–147 (2022).
Xin, H., Liu, D. & Songyang, Z. The telosome/shelterin complex and its functions. Genome Biol. 9, 232 (2008).
Li, T. et al. MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence. Aging 12, 14791–14807 (2020).
Kaul, Z. et al. Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells. Sci. Rep. 11, 17052 (2021).
Luo, Z. et al. Mir-23a induces telomere dysfunction and cellular senescence by inhibiting TRF2 expression. Aging Cell 14, 391–399 (2015).
Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549–1556 (2003).
Chen, K. W. & Chen, J. A. Functional roles of long non-coding RNAs in motor neuron development and disease. J. Biomed. Sci. 27, 38 (2020).
Chuang, J. C. & Jones, P. A. Epigenetics and microRNAs. Pediatr. Res. 61, 24–29 (2007).
Morales, S., Monzo, M. & Navarro, A. Epigenetic regulation mechanisms of microRNA expression. Biomol. Concepts 8, 203–212 (2017).
Li, Y. et al. EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma. Cell Death Differ. 26, 1089–1106 (2019).
Kwa, F. A. A. & Jackson, D. E. Manipulating the epigenome for the treatment of disorders with thrombotic complications. Drug Discov. Today 23, 719–726 (2018).
Yao, Q., Chen, Y. & Zhou, X. The roles of microRNAs in epigenetic regulation. Curr. Opin. Chem. Biol. 51, 11–17 (2019).
Wenfu, Z. et al. DNA methylation-mediated repression of microRNA-410 promotes the growth of human glioma cells and triggers cell apoptosis through its interaction with STAT3. Sci. Rep. 14, 1556 (2024).
Wang, L. et al. miR24-2 promotes malignant progression of human liver cancer stem cells by enhancing tyrosine kinase Src epigenetically. Mol. Ther. 28, 572–586 (2020).
Yang, Y. et al. miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine. J. Cell. Mol. Med. 24, 2772–2790 (2020).
Feng, Y., He, D., Yao, Z. & Klionsky, D. J. The machinery of macroautophagy. Cell Res. 24, 24–41 (2014).
Zhou, Y. et al. A secreted microRNA disrupts autophagy in distinct tissues of Caenorhabditis elegans upon ageing. Nat. Commun. 10, 4827 (2019).
Han, X. et al. MiR-23a promotes autophagy of yak cumulus cells to alleviate apoptosis via the apoptosis signal-regulating kinase 1/c-Jun N-terminal kinase pathway. Theriogenology 212, 50–63 (2023).
Kim, J. et al. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Mol. Neurodegener. 11, 55 (2016).
Waziry, R. et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat. Aging 3, 248–257 (2023).
Boehm, M. & Slack, F. A developmental timing microRNA and its target regulate life span in C. elegans. Science 310, 1954–1957 (2005).
Barrio, L., Dekanty, A. & Milán, M. MicroRNA-mediated regulation of Dp53 in the Drosophila fat body contributes to metabolic adaptation to nutrient deprivation. Cell Rep. 8, 528–541 (2014).
Zhou, Q. et al. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters. Proc. Natl Acad. Sci. USA 108, 8287–8292 (2011).
Sprenkle, N. T. et al. The miR-23-27-24 clusters drive lipid-associated macrophage proliferation in obese adipose tissue. Cell Rep. 42, 112928 (2023).
Amorim, J. A. et al. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat. Rev. Endocrinol. 18, 243–258 (2022).
Duroux-Richard, I., Apparailly, F. & Khoury, M. Mitochondrial microRNAs contribute to macrophage immune functions including differentiation, polarization, and activation. Front. Physiol. 12, 738140 (2021).
Zhang, G.-Q. et al. MicroRNAs regulating mitochondrial function in cardiac diseases. Front. Pharmacol. 12, 663322 (2021).
Dasgupta, N. et al. miRNAs in mtDNA-less cell mitochondria. Cell Death Discov. 1, 15004 (2015).
Zhang, X. et al. MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell 158, 607–619 (2014).
Tak, H. et al. miR-27 regulates mitochondrial networks by directly targeting the mitochondrial fission factor. Exp. Mol. Med. 46, e123 (2014).
Gao, P. et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762–765 (2009).
Faraonio, R. et al. A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ. 19, 713–721 (2012).
Benhamed, M., Herbig, U., Ye, T., Dejean, A. & Bischof, O. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat. Cell Biol. 14, 266–275 (2012).
Pommier, Y., Nussenzweig, A., Takeda, S. & Austin, C. Human topoisomerases and their roles in genome stability and organization. Nat. Rev. Mol. Cell Biol. 23, 407–427 (2022).
Bu, H., Baraldo, G., Lepperdinger, G. & Jansen-Dürr, P. mir-24 activity propagates stress-induced senescence by down regulating DNA topoisomerase 1. Exp. Gerontol. 75, 48–52 (2016).
Röck, K. et al. miR-23a-3p causes cellular senescence by targeting hyaluronan synthase 2: possible implication for skin aging. J. Invest. Dermatol. 135, 369–377 (2015).
Melton, C., Judson, R. L. & Blelloch, R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463, 621–626 (2010).
Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J. A. & Kosik, K. S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137, 647–658 (2009).
Tay, Y., Zhang, J., Thomson, A. M., Lim, B. & Rigoutsos, I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124–1128 (2008).
Witteveldt, J., Knol, L. I. & Macias, S. MicroRNA-deficient mouse embryonic stem cells acquire a functional interferon response. eLife 8, e44171 (2019).
Musto, A. et al. miR-23a, miR-24 and miR-27a protect differentiating ESCs from BMP4-induced apoptosis. Cell Death Differ. 22, 1047–1057 (2015).
Guo, Q., Chen, Y., Guo, L., Jiang, T. & Lin, Z. miR-23a/b regulates the balance between osteoblast and adipocyte differentiation in bone marrow mesenchymal stem cells. Bone Res. 4, 16022 (2016).
Crist, C. G. et al. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc. Natl Acad. Sci. USA 106, 13383–13387 (2009).
Bayraktar, R., Van Roosbroeck, K. & Calin, G. A. Cell-to-cell communication: microRNAs as hormones. Mol. Oncol. 11, 1673–1686 (2017).
Zong, L., Zhu, Y., Liang, R. & Zhao, H.-B. Gap junction mediated miRNA intercellular transfer and gene regulation: a novel mechanism for intercellular genetic communication. Sci. Rep. 6, 19884 (2016).
Li, B. et al. Up-regulated expression of miR-23a/b targeted the pro-apoptotic Fas in radiation-induced thymic lymphoma. Cell. Physiol. Biochem. 32, 1729–1740 (2013).
Li, H. et al. Bone marrow mesenchymal stem cell extracellular vesicle-derived miR-27b- 3p activates the Wnt/Β-catenin pathway by targeting SMAD4 and aggravates hepatic ischemia-reperfusion injury. Curr. Stem Cell Res. Ther. 19, 755–766 (2024).
Terana, G., Abd-Alhaseeb, M., Omran, G. & M. Okda, T. Quercetin potentiates 5-fluorouracil effects in human colon cancer cells through targeting the Wnt/β-catenin signalling pathway: the role of miR-27a. Contemp. Oncol. 26, 229–238 (2022).
Li, Y., Tan, J., Miao, Y. & Zhang, Q. MicroRNA in extracellular vesicles regulates inflammation through macrophages under hypoxia. Cell Death Discov. 7, 285 (2021).
Obora, K. et al. Inflammation-induced miRNA-155 inhibits self-renewal of neural stem cells via suppression of CCAAT/enhancer binding protein β (C/EBPβ) expression. Sci. Rep. 7, 43604 (2017).
Zhu, S. et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat. Med. 18, 1077–1086 (2012).
Hu, J. et al. MiR-23a inhibited IL-17-mediated proinflammatory mediators expression via targeting IKKα in articular chondrocytes. Int. Immunopharmacol. 43, 1–6 (2017).
Ma, S. et al. A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression. Oncotarget 7, 13502–13519 (2016).
Maegdefessel, L. et al. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat. Commun. 5, 5214 (2014).
Wu, C.-J. et al. MiR-23~27~24–mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation. Sci. Adv. 5, eaaw1715 (2019).
Lee, M. et al. Loss of microRNA-23-27-24 clusters in skeletal muscle is not influential in skeletal muscle development and exercise-induced muscle adaptation. Sci. Rep. 9, 1092 (2019).
Tsuchikawa, Y. et al. Deficiency of microRNA-23-27-24 clusters exhibits the impairment of myelination in the central nervous system. Neural Plast. 2023, 8938674 (2023).
Oikawa, S., Wada, S., Lee, M., Maeda, S. & Akimoto, T. Role of endothelial microRNA-23 clusters in angiogenesis in vivo. Am. J. Physiol. Heart Circ. Physiol. 315, H838–H846 (2018).
Acknowledgements
We apologize to researchers not cited in the manuscript due to limited space. Special thanks to Dr. John O’Brien for further editing the manuscript. Work in the Jun-An Chen laboratory is supported by grants from the Academia Sinica (AS-GCP-113-L02 and AS-BRPT-113-01), the National Science & Technology Council (112-2326-B-001-001), and the National Health Research Institutes (NHRI-EX113-11330NI).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yap, X.L., Chen, JA. Elucidation of how the Mir-23-27-24 cluster regulates development and aging. Exp Mol Med (2024). https://doi.org/10.1038/s12276-024-01266-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s12276-024-01266-3
- Springer Nature Limited